Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis
J. L. Cantera, L. M. Lillis, R. B. Peck, E. Moreau, J. A. Schouten, P. Davis, P. K. Drain, A. Andama, A. Pinter, M. Kawasaki, G. Kallenius, C. Sundling, K. M. Dobos, D. Flores, D. Chatterjee, E. Murphy, O. R. Halas, D. S. Boyle
Abstract
Lipoarabinomannan (LAM), a component of the Mycobacterium tuberculosis (MTB) cell wall, is detectable in the urine of MTB infected patients with active tuberculosis (TB). LAM-specific antibodies (Igs) have been developed by a variety of traditional and recombinant methods for potential use in a rapid diagnostic test (RDT). We evaluated the analytical performance of the TB LAM Igs to identify pairs that offer superior performance over existing urine LAM tests. We assessed 25 new and 4 existing Igs in a matrixed format using a multiplex electrochemiluminescence-based liquid immunoassay. A total of 841 paired Ig combinations were challenged with in vitro cultured LAM (cLAM) derived from MTB strains representing diverse phylogenetic lineages, alongside urinary LAM (uLAM) from the urine of adults with active pulmonary TB. Analytical sensitivity of down-selected Ig pairs was determined using MTB Aoyama-B cLAM, while diagnostic accuracy was determined using clinical samples. When testing cLAM, the reactivity of Ig pairs was similar across MTB lineages 1-4 but lineage 5:6 had significantly more reactivity among Ig pairs. Overall, 41 Ig pairs had a strong binding affinity to cLAM, as compared to the reference pair of S4-20/A194-01, and 28 Ig pairs therein exhibited a strong affinity for both cLAM and uLAM. Retrospective testing on clinical urine specimens demonstrated varying sensitivities (12-80%) and specificities (14-100%). The five top pairs had a similar analytical limit of detection to the reference pair but in four instances, the sensitivity and specificity with clinical uLAM samples was poor. Overall, epitopes presented by uLAM are different from cLAM, which may affect antibody performance when testing uLAM in patient samples. Several new Ig pairs had similar ranges of high sensitivity to cLAM but overall, there were no new candidate Ig pairs identified in this round of screening with increased performance with uLAM as compared to an existing optimal pair.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel human monoclonal antibodies with enhanced sensitivity for lipoarabinomannan antigens present in urines of TB patients
Alok Kumar Choudhary, Deendayal Patel, … Abraham Pinter·bioRxiv·Jul 27, 2026
- Isolation and Purification of Lipoarabinomannan from Urine of Adults with Active Tuberculosis
J. L. Cantera, A. Rashid, … D. S. Boyle·bioRxiv·Mar 24, 2021
- Interaction of Amphiphilic Lipoarabinomannan with Host Carrier Lipoproteins in Tuberculosis Patients: Implications for Blood-based Diagnostics.
H. Mukundan, S. Jakhar, … S. E. Dorman·bioRxiv·Nov 20, 2020
- Pathogen and host biomarkers to aid early diagnosis and prognosis of tuberculous meningitis
Urvashi Balbir Singh, K. P. Angitha, … Uma Kanga·InfectionPeer-reviewed·Oct 8, 2026
- Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from saliva
J. Hansen, K. Kolbe, … N. Reiling·bioRxiv·Mar 4, 2022
- Immune profiling in M. tuberculosis infection enables stratification of patients with active disease
D. Duffy, E. Nemes, … M. L. Albert·bioRxiv·Mar 18, 2019